Micah Etter, MD
banner
mettermd.bsky.social
Micah Etter, MD
@mettermd.bsky.social
very cool guy doing (mostly) inpatient/vascular #Neurology (rumored). passionate re:edu/medtraining/8bit/+! posts are mine. he/him
Pinned
🚨New thing release announcement! 🚨

StrokeBot.me is a free stroke code simulator for trainees! Practice workflows, interventions, disposition calls, and more!

This is just the initial release so bugs are expected and updates ongoing! Enjoy!

#Neurology #MedEd
StrokeBot.me - Acute Stroke Simulator
StrokeBot.me
Reposted by Micah Etter, MD
What are the perceptions of clinicians referring to a novel pediatric #neuropalliative clinic? In the latest issue of #pedneuro, Lin et al explores these perceptions.

Read here: buff.ly/v2nBte7
December 26, 2025 at 6:03 PM
Reposted by Micah Etter, MD
Emergency Medicaid accounts for less than 1% of total #Medicaid spending, even in states with large undocumented populations.

ja.ma/3Yx9hDD
December 26, 2025 at 7:15 PM
Reposted by Micah Etter, MD
Brainstem lesions in MS are also perivenular, often appearing radially in a "sunray" pattern. Authors include Dr. Gavin Giovannoni and Dr. Dr. Klaus Schmierer pubmed.ncbi.nlm.nih.gov/41447908/
December 26, 2025 at 10:49 PM
Reposted by Micah Etter, MD
State Medicaid Expansions and Mortality, Revisited:

Medicaid expansions led to declines in all-cause mortality of 6%; HIV-related mortality accounted for 20 percent of the effect.
www.journals.uchicago.edu/doi/abs/10.1...
State Medicaid Expansions and Mortality, Revisited: A Cost-Benefit Analysis | American Journal of Health Economics: Vol 3, No 3
Previous research found that Medicaid expansions in New York, Arizona, and Maine in the early 2000s reduced mortality. I revisit this question with improved data and methods, exploring distinct causes...
www.journals.uchicago.edu
December 26, 2025 at 9:34 AM
Reposted by Micah Etter, MD
Valacyclovir was associated with greater cognitive decline and did not improve disease markers in patients with symptomatic #AlzheimerDisease and HSV seropositivity.

ja.ma/4qydeE1
December 27, 2025 at 1:00 PM
Reposted by Micah Etter, MD
1/ 👋 there #neurotwitter #neurosky #neurocritcare, and Happy Holidays if you celebrate! As part of my @neurocritcarej #SoMeAmbassador role, today we will be breaking down the following article: link.springer.com/ar... about consent in research involving #DoC
December 23, 2025 at 9:01 PM
HEY EVERYBODY!

i'm back! did you miss me?🙃

i was so busy co-directing the neuro block
@UAZMedTucson
for 1st year med students that I haven't been around as much... but it gave me time to make LOTS of fun stuff!

i'll be gradually releasing, but let's start with...**drumroll**
December 22, 2025 at 8:24 PM
Reposted by Micah Etter, MD
On September 24, ERAS will open to programs. Which means applicants have only 2 weeks left to decide which programs to signal.

And if you want to know how to allocate your signals in the most effective manner possible, I’ve got something for you:

thesheriffofsodium.com/2025/09/10/t...
The Applicant’s Guide to Strategic Preference Signaling
Whenever I discuss preference signaling on social media, one of the first replies is always “Wait – what’s that?” In the olden days, when an applicant was interested in a particular residency…
thesheriffofsodium.com
September 11, 2025 at 12:53 AM
Reposted by Micah Etter, MD
1/ Hello #medsky #neurosky #neurocritcare #FOAMEd have another brief case that I wanted to discuss with you and see if maybe you can learn something new or reinforce old knowledge!
September 3, 2025 at 8:00 PM
🚨NEW RELEASE🚨

🔍Daily neurology connections, anyone?

neuroconnections.me has launched with a free, fun micro-learning puzzle game every day! Still the initial release so let me know if you spot any bugs.🐛

Play and learn here: neuroconnections.me

#Neurology #MedEd
🧠 NeuroConnections
NeuroConnections.me
September 1, 2025 at 5:25 PM
🚨New thing release announcement! 🚨

StrokeBot.me is a free stroke code simulator for trainees! Practice workflows, interventions, disposition calls, and more!

This is just the initial release so bugs are expected and updates ongoing! Enjoy!

#Neurology #MedEd
StrokeBot.me - Acute Stroke Simulator
StrokeBot.me
August 26, 2025 at 4:44 PM
Reposted by Micah Etter, MD
Could a metal ion supplement that cost pennies per day protect from Alzheimer's disease?
erictopol.substack.com/p/lithium-an...
August 10, 2025 at 3:14 PM
Reposted by Micah Etter, MD
October 13, 2024 at 4:11 AM
Reposted by Micah Etter, MD
1/ Hello #medsky #neurosky #neurocritcare #FOAMEd have a brief case that I wanted discuss with you and see if maybe you can learn something new or reinforce old knowledge!
August 6, 2025 at 8:00 PM
Reposted by Micah Etter, MD
A 50-year-old woman presented to the emergency department with a 10-day history of a throbbing headache that had suddenly started after she had felt a “pop” in her back. The headache worsened with upright positioning and improved with lying flat. 1/4

#MedSky
July 24, 2025 at 7:06 PM
Reposted by Micah Etter, MD
Case series w/ cumulative total n=110 pts support use of rivastigmine as alternative antidote to physostigmine for anticholinergic delirium. Both oral & transdermal formulations of rivastigmine may expedite recovery #medsky #EMsky #pharmsky #emimcc #FOAMed

👉 link.springer.com/article/10.1...
Just the facts: rivastigmine for the management of anticholinergic toxicity - Canadian Journal of Emergency Medicine
Canadian Journal of Emergency Medicine -
link.springer.com
July 14, 2025 at 6:40 PM
Reposted by Micah Etter, MD
OpenEvidence is generally very good, but it's occasionally horrifically wrong

One place it falls down a lot is drug allergy (where it's often too conservative)

There are NO absolute contraindications to acetylcysteine for acetaminophen OD

Reported "allergy" = anaphylactoid rxns... (#1/3) #EMIMCC
July 6, 2025 at 2:26 PM
Reposted by Micah Etter, MD
You had MS even before you had symptoms. This study found increased absenteeism from work 6 years prior to diagnosis. jnnp.bmj.com/content/earl...
Prodromal phase of multiple sclerosis: evidence from sickness absence patterns before disease onset – a matched cohort study
Background We aimed to investigate the prodromal phase of multiple sclerosis (MS) by investigating annual sickness absence rates before MS onset. Methods A retrospective cohort study was conducted us...
jnnp.bmj.com
June 29, 2025 at 4:12 PM
Reposted by Micah Etter, MD
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!

Practice changing investigator-initiated RCT.

#ISTH2025
June 22, 2025 at 1:49 PM
Reposted by Micah Etter, MD
Peer review is being transformed by AI, whether we like it or not.

From my own experience, most researchers are using it wrong… and that’s because no one’s talking about it! Let me share some ideas on how to harness its potential to improve scientific publishing.
June 15, 2025 at 2:21 PM
Reposted by Micah Etter, MD
Herpes zoster vaccination eligibility reduced the probability of new dementia diagnoses, suggesting its potential preventive effect.

https://ja.ma/4lagSB6
June 22, 2025 at 1:00 PM
Reposted by Micah Etter, MD
What is the prevalence of elevated opening pressure in children with Alexander Disease?

In the current issue of #pedneuro journal, Joung et al. explore this question through analysis of opening pressure, MRI and examination in a cohort of 43 patients.

Read Here: buff.ly/UrvyLjh
June 22, 2025 at 4:04 PM
Reposted by Micah Etter, MD
INDEX trial: CT perfusion wasn't adequate for evaluating brain death.

huge problem: they're using clinical exam as the gold standard

I think most patients classified as brain dead by CT perfusion but alive by exam were dead... #1/2

#EMIMCC #CCR25
June 13, 2025 at 3:53 PM
"Plasma p-tau217 reliably identified clinic patients with Alzheimer's"🆒

"definitive results in 86% of patients" 🆒

"Integration of plasma Aβ42 minimally improved diagnostic performance"🐟

"Plasma p-tau217 levels were increased in patients with kidney dysfunction"🫘
Diagnostic performance of plasma p‐tau217 and Aβ42/40 biomarkers in the outpatient memory clinic
INTRODUCTION Plasma biomarkers of Alzheimer's disease (AD) represent accessible alternatives to positron emission tomography (PET) and cerebrospinal fluid (CSF)-based biomarkers in well-characterize.....
alz-journals.onlinelibrary.wiley.com
June 12, 2025 at 10:05 PM